General
Preferred name
OXYMORPHONE
Synonyms
IDS-NO-003 ()
14-hydroxydihydromorphinone ()
Oximorfona ()
NIH 10323 ()
NSC-19045 ()
Dihydroxymorphinone ()
Oxymorphone cii ()
Oxycodone hydrochloride impurity, oxymorphone- ()
7,8-dihydro-14-hydroxymorphinone ()
Opana Er ()
Oxymorphone hcl ()
Numorphan ()
Opana ()
OXYMORPHONE HYDROCHLORIDE ()
Oxymorphone (hydrochloride) ()
P&D ID
PD009750
CAS
76-41-5
357-07-3
Tags
available
drug
Approved by
FDA
First approval
1959
Drug indication
Pain
Drug Status
approved
vet_approved
Max Phase
4.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Oxymorphone is a semi-synthetic opioid drug. (GtoPdb)
TOXICITY Oxymorphone overdosage is characterized by respiratory depression, extreme somnolence progressing to stupor or coma, skeletal muscle flaccidity, cold and clammy skin, and sometimes bradycardia and hypotension. Patients experiencing an overdose may develop apnea, circulatory collapse, and cardiac arrest. Intravenous mouse LD50 is 172 mg/kg.; ;
Cell lines
0
Organisms
2
Compound Sets
12
Cayman Chemical Bioactives
ChEMBL Approved Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
NCATS Inxight Approved Drugs
External IDs
114
Properties
(calculated by RDKit )
Molecular Weight
301.13
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
2
Rotatable Bonds
0
Ring Count
5
Aromatic Ring Count
1
cLogP
0.75
TPSA
70.0
Fraction CSP3
0.59
Chiral centers
4.0
Largest ring
6.0
QED
0.74
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Therapeutic Class
Neurology Agents
Source data